MJBizDaily
FDA approved cannabis: Why Schedule 3 means operators must prepare for pharmaceutical-grade MMJ now
Featured
Latest Posts
Massachusetts cannabis industry launches campaign to stop adult-use sales repeal
The Stop the Repeal campaign debut drew cannabis business owners, healthcare professionals and elected officials to the State House steps.
News June 25How Aurora Cannabis plans to enter the US market
The company runs medical cannabis operations in 12 countries and has built its business around good manufacturing practices.
News June 25Connecticut to boost cannabis industry participation with tribal compact
New competition could come to Connecticut's constricted cannabis market from tribal marijuana enterprises.
News June 24California city legalizes cannabis consumption lounges, but national progress uneven
While Sacramento is pushing ahead with consumption lounges, progress toward allowing them in Massachusetts has crawled.
News June 24What to expect from the DEA marijuana rescheduling hearing
The top DEA administrative law judge will once again hear arguments for and against downgrading marijuana's status under federal law, but marijuana rescheduling is not guaranteed.
News June 24Maine adult-use cannabis sales repeal effort returns, claims to be on track
A campaign to repeal adult-use marijuana sales in Maine has returned and is gaining momentum, organizers claimed.
News June 23Nebraska medical marijuana cultivator finally approved to start growing
MahaMota Cultivation Co. will become the first licensed medical marijuana cultivator to put plants in the ground.
News June 23Cannabis loyalty isn’t built on THC, it’s built on trust
Low-dose products, microdosed beverages and experience-based merchandising may prove more scalable for consumer retention than a perpetual potency race.
News June 23Tennessee retailers brace for revenue hit as hemp ban takes effect
Nebraska governor orders changes to rules reclassifying consumable hemp products as adulterated to protect children.
News June 22













